These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6673867)

  • 1. [Serum muscle-specific enolase levels in neuromuscular diseases--possibility as a new specific marker for muscular disorders].
    Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K
    Rinsho Shinkeigaku; 1983 Oct; 23(10):852-60. PubMed ID: 6673867
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum muscle-specific enolase in progressive muscular dystrophy and other neuromuscular diseases.
    Mokuno K; Riku S; Matsuoka Y; Sobue I; Kato K
    J Neurol Sci; 1984 Mar; 63(3):345-52. PubMed ID: 6726277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic implication of nonspecific esterase stain on biopsied muscles in various neuromuscular disorders].
    Ishihara T
    Rinsho Shinkeigaku; 1984 Mar; 24(3):248-55. PubMed ID: 6205809
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of neuron-specific enolase as a serum marker for neuroendocrine neoplasms.
    Prinz RA; Marangos PJ
    Surgery; 1982 Nov; 92(5):887-9. PubMed ID: 7135210
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of muscle enzyme measurement in evaluating different neuromuscular diseases.
    Zhang Y; Huang JJ; Wang ZQ; Wang N; Wu ZY
    Clin Chim Acta; 2012 Feb; 413(3-4):520-4. PubMed ID: 22137979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of muscular histoenzymological and electromyographic findings in human neuromuscular pathology. Methods and preliminary results].
    Castaigne P; Cathala HP; Rouques C; Beaussart-Boulenge L; Dammame P; Jarnot N
    Rev Neurol (Paris); 1974; 130(1-2):5-19. PubMed ID: 4153961
    [No Abstract]   [Full Text] [Related]  

  • 7. Total and immunologically reacting muscle enolase in blood serum of Duchenne muscular dystrophy patients and carriers.
    Goldberg DM; Rider CC; Taylor CB
    Clin Chim Acta; 1976 Aug; 71(1):89-93. PubMed ID: 971527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum neuron-specific enolase in patients with non-pulmonary neoplasms].
    Ruibal A; Miralles EM; Encabo G; Sampere S
    Med Clin (Barc); 1986 Feb; 86(7):303. PubMed ID: 3713347
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critical analysis of the results of muscle biopsies and of the methods used in 889 cases of neuromuscular disorders].
    Deruaz JP; Janzer RC
    Schweiz Rundsch Med Prax; 1994 Jan; 83(4):101-5. PubMed ID: 8115761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of the patients with neurological diseases].
    Mokuno K; Kato K; Kawai K; Matsuoka Y; Sobue I
    Rinsho Shinkeigaku; 1983 May; 23(5):397-403. PubMed ID: 6883882
    [No Abstract]   [Full Text] [Related]  

  • 11. [Postburn change in the plasma level of neuron specific enolase in burned patients with cerebral malfunction].
    Wang GQ; Wang ZG; Xiao SC; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2003 Dec; 19(6):347-8. PubMed ID: 14761643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates.
    Dabby R; Sadeh M; Herman O; Berger E; Watemberg N; Hayek S; Jossiphov J; Nevo Y
    Isr Med Assoc J; 2006 Feb; 8(2):110-3. PubMed ID: 16544734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LDH isoenzymes in muscle diseases.
    Dux L; László A; Mazareán H; Altorjay I
    Acta Paediatr Acad Sci Hung; 1980; 21(1):19-26. PubMed ID: 7446085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of serum neuron specific enolase in local and widespread neuroblastoma.
    Zeltzer PM; Marangos PJ; Sather H; Evans A; Siegel S; Wong KY; Dalton A; Seeger R; Hammond D
    Prog Clin Biol Res; 1985; 175():319-29. PubMed ID: 3991735
    [No Abstract]   [Full Text] [Related]  

  • 15. Nerve contact with muscle component in neuromuscular hamartoma.
    Kusuzaki K; Emoto K; Murata H; Katsura K; Sugihara H; Tsuchihashi Y; Hirasawa Y
    Anticancer Res; 2000; 20(5C):3807-11. PubMed ID: 11268458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Musculoskeletal diseases in general practice].
    Borchgrevink CF; Brekke TH; Ogar B
    Tidsskr Nor Laegeforen; 1980 Mar; 100(7):439-45. PubMed ID: 7385199
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum neuron-specific enolase as a predictor of short-term outcome in children with closed traumatic brain injury.
    Bandyopadhyay S; Hennes H; Gorelick MH; Wells RG; Walsh-Kelly CM
    Acad Emerg Med; 2005 Aug; 12(8):732-8. PubMed ID: 16079426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The determination of neuron-specific enolase of serum in the diagnosis and supervision of retinoblastoma].
    Wu Z; Mao Y; Yang H; Pan S; Chen Z
    Zhonghua Yan Ke Za Zhi; 1998 Mar; 34(2):117-20. PubMed ID: 11877170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass].
    Gu XH; Zhang G; Zhang XQ; Song Y; Wang T; Li SX
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):975-7. PubMed ID: 17650423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle enzymes-A possible marker for prediction of neuromuscular toxicity in OPC poisoning.
    Siqueira RD; Rodrigues CJ; Nadkarni PV; Ghanekar MA
    J Assoc Physicians India; 1990 Sep; 38(9):667. PubMed ID: 2266092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.